Patients with familial hypercholesterolemia were found to be at increased risk for long-term mortality and cardiovascular events after acute myocardial infarction.
Higher intake of whole-fat dairy products is associated with a lower prevalence of metabolic syndrome (MetS) as well as hypertension and diabetes.
Experts proposed new guidelines on the diagnosis of metabolic-associated fatty liver disease (MAFLD), formerly non-alcohol fatty liver disease (NAFLD).
A risk score based on 10 factors can predict the risk for developing critical illness at COVID-19 admission.
Subcutaneous administration of inclisiran every 6 months was found to reduce low-density lipoprotein cholesterol by 50% in patients with atherosclerotic cardiovascular disease.
Certain components of metabolic syndrome may be more common in patients with Parkinson disease who are carriers of an LRRK2 mutation compared with other PD etiologies.
Adolescents with obesity or type 2 diabetes are at increased risk for progression of cardiovascular risk factors and accelerated early vascular aging.
Treatment with statins was found to reduce the risk for disease recurrence in patients with venous thromboembolism.
Dolutegravir-based regimen may lead to significant improvement in lipids blood concentration, but relevant increases in trunk fat without alterations of body mass index.
Upward income mobility is associated with lower perceived stress and fewer depressive symptoms but with higher rates of metabolic syndrome.
In national patient registries, cardiovascular disease risk and diabetes management varied by geographic region in the United States.